FDA NDC Directory · JSON-LD · Markdown

OSVYRTI

NDC 69448-021 · HUMAN PRESCRIPTION DRUG · INJECTION

Generic namedenosumab-desu
Labeler / ManufacturerAccord BioPharma Inc.
Marketing categoryBiologic License Application · App BLA761424
Dosage form / routeINJECTION · SUBCUTANEOUS
Active ingredientsDENOSUMAB (60 mg/mL)
Marketing started20260706
Package count1

External sources

Source: openFDA. Public-domain (CC0).